HUP0203121A3 - Pharmaceutical composition containing substituted benzimidazoles and its use - Google Patents

Pharmaceutical composition containing substituted benzimidazoles and its use

Info

Publication number
HUP0203121A3
HUP0203121A3 HU0203121A HUP0203121A HUP0203121A3 HU P0203121 A3 HUP0203121 A3 HU P0203121A3 HU 0203121 A HU0203121 A HU 0203121A HU P0203121 A HUP0203121 A HU P0203121A HU P0203121 A3 HUP0203121 A3 HU P0203121A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
composition containing
containing substituted
substituted benzimidazoles
benzimidazoles
Prior art date
Application number
HU0203121A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0203121A2 publication Critical patent/HUP0203121A2/hu
Publication of HUP0203121A3 publication Critical patent/HUP0203121A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
HU0203121A 1999-10-22 2000-10-13 Pharmaceutical composition containing substituted benzimidazoles and its use HUP0203121A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903831A SE9903831D0 (sv) 1999-10-22 1999-10-22 Formulation of substituted benzimidazoles
PCT/SE2000/001992 WO2001028558A1 (en) 1999-10-22 2000-10-13 Formulation of substituted benzimidazoles

Publications (2)

Publication Number Publication Date
HUP0203121A2 HUP0203121A2 (hu) 2003-01-28
HUP0203121A3 true HUP0203121A3 (en) 2004-01-28

Family

ID=20417464

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203121A HUP0203121A3 (en) 1999-10-22 2000-10-13 Pharmaceutical composition containing substituted benzimidazoles and its use

Country Status (36)

Country Link
US (1) US6730685B1 (hu)
EP (1) EP1274427B1 (hu)
JP (1) JP2003512327A (hu)
KR (1) KR100785603B1 (hu)
CN (1) CN1213751C (hu)
AR (1) AR029005A1 (hu)
AT (1) ATE304851T1 (hu)
AU (1) AU782866B2 (hu)
BG (1) BG65580B1 (hu)
BR (1) BR0014895A (hu)
CA (1) CA2425199C (hu)
CO (1) CO5261533A1 (hu)
CY (1) CY1106055T1 (hu)
CZ (1) CZ20021375A3 (hu)
DE (1) DE60022789T2 (hu)
DK (1) DK1274427T3 (hu)
EE (1) EE05175B1 (hu)
ES (1) ES2246903T3 (hu)
HK (1) HK1051142A1 (hu)
HU (1) HUP0203121A3 (hu)
IL (2) IL149107A0 (hu)
IS (1) IS2196B (hu)
MX (1) MXPA02003900A (hu)
MY (1) MY131971A (hu)
NO (1) NO329545B1 (hu)
NZ (1) NZ518155A (hu)
PL (1) PL199868B1 (hu)
RU (1) RU2286782C2 (hu)
SE (1) SE9903831D0 (hu)
SI (1) SI1274427T1 (hu)
SK (1) SK286266B6 (hu)
TR (1) TR200201103T2 (hu)
TW (1) TWI236372B (hu)
UA (1) UA74347C2 (hu)
WO (1) WO2001028558A1 (hu)
ZA (1) ZA200202905B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2775616C (en) * 2000-08-04 2013-09-17 Takeda Pharmaceutical Company Limited Salts of benzimidazole compound and application thereof
EP1310252A4 (en) * 2000-08-18 2009-06-10 Takeda Pharmaceutical INJECTIONS
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
US7507746B2 (en) * 2003-02-24 2009-03-24 Mitsubishi Pharma Corporation Enantiomer of tenatoprazole and the use thereof in therapy
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060089376A1 (en) * 2004-10-27 2006-04-27 Joshi Ramesh A Tenatoprazole salts and process of preparation thereof
WO2007129961A1 (en) * 2006-05-09 2007-11-15 Astrazeneca Ab Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
CN100411613C (zh) * 2006-12-08 2008-08-20 中国药科大学 一种奥美拉唑速释固体制剂及其制备方法
US10415073B2 (en) 2014-11-13 2019-09-17 3M Innovative Properties Company Kit comprising ATP-diphosphohydrolase for detecting bacterial ATP in a sample
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
DK399389A (da) 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
KR930000861B1 (ko) 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물
AU674015B2 (en) 1992-07-28 1996-12-05 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
TW359614B (en) 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
DE69940769D1 (de) * 1998-01-20 2009-06-04 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
EP1274427B1 (en) 2005-09-21
KR20020059637A (ko) 2002-07-13
CA2425199C (en) 2010-12-07
BG106602A (en) 2002-12-29
CO5261533A1 (es) 2003-03-31
WO2001028558A1 (en) 2001-04-26
HUP0203121A2 (hu) 2003-01-28
PL199868B1 (pl) 2008-11-28
NO20021860D0 (no) 2002-04-19
DK1274427T3 (da) 2005-12-27
RU2286782C2 (ru) 2006-11-10
AR029005A1 (es) 2003-06-04
NZ518155A (en) 2004-07-30
CA2425199A1 (en) 2001-04-26
BR0014895A (pt) 2002-06-18
CZ20021375A3 (cs) 2002-09-11
IL149107A0 (en) 2002-11-10
IS2196B (is) 2007-01-15
TR200201103T2 (tr) 2002-08-21
ATE304851T1 (de) 2005-10-15
DE60022789D1 (de) 2006-02-02
DE60022789T2 (de) 2006-06-22
NO329545B1 (no) 2010-11-08
TWI236372B (en) 2005-07-21
EP1274427A1 (en) 2003-01-15
MXPA02003900A (es) 2002-09-30
MY131971A (en) 2007-09-28
PL354926A1 (en) 2004-03-22
CN1382048A (zh) 2002-11-27
CN1213751C (zh) 2005-08-10
KR100785603B1 (ko) 2007-12-14
ES2246903T3 (es) 2006-03-01
EE200200204A (et) 2003-04-15
CY1106055T1 (el) 2011-04-06
BG65580B1 (bg) 2009-01-30
SI1274427T1 (sl) 2006-02-28
EE05175B1 (et) 2009-06-15
ZA200202905B (en) 2003-07-14
IS6347A (is) 2002-04-17
IL149107A (en) 2008-04-13
NO20021860L (no) 2002-05-21
SK5392002A3 (en) 2002-10-08
HK1051142A1 (en) 2003-07-25
US6730685B1 (en) 2004-05-04
UA74347C2 (uk) 2005-12-15
SE9903831D0 (sv) 1999-10-22
JP2003512327A (ja) 2003-04-02
SK286266B6 (sk) 2008-06-06
AU1182301A (en) 2001-04-30
AU782866B2 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0200831A2 (en) Novel pharmaceutical composition containing amoxycillin and its use
HUP0200548A2 (hu) Gyógyszerészeti készítmények és alkalmazásuk
HUP0203556A3 (en) Pharmaceutical compositions containing oxcarbazepine and their use
HUP0302969A3 (en) Npyy5 antagonists, pharmaceutical compositions containing them and their use
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP0203638A3 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them and their use
HUP0203895A3 (en) Substituted azaindoles and pharmaceutical compositions containing them and their use
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
IL148517A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
HUP0200879A2 (en) Pharmaceutical composition for dermal use
IL150077A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL155937A0 (en) Imidazole and benzimidazole derivatives and pharmaceutical compositions containing the same
IL149883A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0203121A3 (en) Pharmaceutical composition containing substituted benzimidazoles and its use
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees